Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Plaque Psoriasis”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01988103
What this trial is testing

Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type Psoriasis

Who this might be right for
PsoriasisPsoriatic ArthritisPsoriasis Arthropatica
Amgen 254
Post-approval studies (Phase 4)Study completedNCT03988439
What this trial is testing

A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque Psoriasis

Who this might be right for
Psoriasis
Bausch Health Americas, Inc. 16
Large-scale testing (Phase 3)Study completedNCT01276639
What this trial is testing

A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 901
Testing effectiveness (Phase 2)Study completedNCT02413229
What this trial is testing

Double Blind Vehicle Controlled Dose Ranging Parallel Design Multiple Site Clinical Study

Who this might be right for
Plaque Psoriasis
Sun Pharmaceutical Industries, Inc. 151
Large-scale testing (Phase 3)Study completedNCT03210259
What this trial is testing

The VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira® and BI 695501 in Patients With Plaque Psoriasis

Who this might be right for
Psoriasis
Boehringer Ingelheim 259
Large-scale testing (Phase 3)Study completedNCT00307437
What this trial is testing

The Safety and Efficacy of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
Centocor Research & Development, Inc. 1,230
Testing effectiveness (Phase 2)Study completedNCT06176768
What this trial is testing

LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Eli Lilly and Company 33
Large-scale testing (Phase 3)Study completedNCT02016105
What this trial is testing

Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira

Who this might be right for
Plaque Type Psoriasis
Sandoz 465
Large-scale testing (Phase 3)Study completedNCT03051217
What this trial is testing

Test the Efficacy and Safety of Certolizumab Pegol in Japanese Subjects With Moderate to Severe Chronic Psoriasis

Who this might be right for
Moderate to Severe PsoriasisGeneralized Pustular Psoriasis and Erythrodermic Psoriasis
UCB Biopharma S.P.R.L. 127
Post-approval studies (Phase 4)Study completedNCT00833729
What this trial is testing

The Safety & Efficacy of Etanercept in Psoriasis Patients Who Have Not Responded to Adalimumab

Who this might be right for
Plaque Psoriasis
Dermatrials Research 10
Early research (Phase 1)UnknownNCT04367441
What this trial is testing

Randomized, Double Blinded, Placebo Controlled, Single Dose Escalation Study of 608 in Healthy Subjects

Who this might be right for
Moderate to Severe Plaque Psoriasis
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 62
Large-scale testing (Phase 3)Study completedNCT03875508
What this trial is testing

Assess Usability of Risankizumab Autoinjector Combination Product in Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie 108
Large-scale testing (Phase 3)Study completedNCT02267135
What this trial is testing

Efficacy and Safety of Subcutaneous Secukinumab in Adults With Moderate to Severe Scalp Psoriasis

Who this might be right for
Chronic Scalp Psoriasis
Novartis Pharmaceuticals 102
Large-scale testing (Phase 3)Not Yet RecruitingNCT07752108
What this trial is testing

Zasocitinib in Adults With Non-pustular Palmoplantar Psoriasis

Who this might be right for
Palmoplantar Psoriasis
Takeda 40
Large-scale testing (Phase 3)Ended earlyNCT01708629
What this trial is testing

Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects

Who this might be right for
Plaque Psoriasis
Bausch Health Americas, Inc. 1,881
Testing effectiveness (Phase 2)WithdrawnNCT02011269
What this trial is testing

TSO for Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Coronado Biosciences, Inc.
Testing effectiveness (Phase 2)Study completedNCT01300052
What this trial is testing

AN2728 Topical Ointment to Treat Mild-to-Moderate Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Pfizer 68
Testing effectiveness (Phase 2)Study completedNCT01585233
What this trial is testing

A Multiple Dose Escalation Study of ASKP1240 in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Astellas Pharma Global Development, Inc. 60
Not applicableStudy completedNCT04823247
What this trial is testing

Observational Real-world Evidence (RWE) Study to Assess Patient-reported Wellbeing Using Tildrakizumab in Live Setting - POSITIVE Study

Who this might be right for
Plaque Psoriasis
Almirall, S.A. 782
Not applicableLooking for participantsNCT06382051
What this trial is testing

Modifying PEST for Psoriatic Arthritis Screening

Who this might be right for
Plaque PsoriasisPsoriatic Arthritis
Novartis Pharmaceuticals 502
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation